Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| VSORA | 2025 | Venture - Series Unknown | $45.6M | La Forêt |
| DePoly | 2025 | Seed | $23.0M | Sion |
| AMT Medical | 2025 | Series B | $24.9M | Utrecht |
| Skytree | 2025 | Series A | Undisclosed | Amsterdam |
| Sparrow Quantum | 2025 | Series A | $24.2M | Copenhagen |
| Bloom Biorenewables Ltd | 2025 | Series A | $14.7M | Fribourg |
| Marvel Fusion | 2025 | Series B | $53.9M | Munich |
| Brevel | 2025 | Seed | $5.0M | Shekef |
| Valo Therapeutics | 2025 | Venture - Series Unknown | $20.6M | Helsinki |
| Osivax | 2025 | Series B | $10.5M | Lyon |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | VSORA | Venture - Series Unknown | $45.6M | La Forêt, France |
| 52 | DePoly | Seed | $23.0M | Sion, Switzerland |
| 53 | AMT Medical | Series B | $24.9M | Utrecht, The Netherlands |
| 54 | Skytree | Series A | Undisclosed | Amsterdam, The Netherlands |
| 55 | Sparrow Quantum | Series A | $24.2M | Copenhagen, Denmark |
| 56 | Bloom Biorenewables Ltd | Series A | $14.7M | Fribourg, Switzerland |
| 57 | Marvel Fusion | Series B | $53.9M | Munich, Germany |
| 58 | Brevel | Seed | $5.0M | Shekef, Israel |
| 59 | Valo Therapeutics | Venture - Series Unknown | $20.6M | Helsinki, Finland |
| 60 | Osivax | Series B | $10.5M | Lyon, France |
VSORA is an IP provider for chipmakers designing the latest generations of digital communications systems, such as 5G.
DePoly is a PET-to-raw-material recycling company that converts dirty, post-consumer plastic items into valuable raw materials.
Developed a minimal invasive cardiac bypass device
Transforming CO2 supply
Sparrow Quantum develope and commercializes photonic quantum chip technology.
Bloom Biorenewables is making biomass a true alternative to petroleum.
Marvel Fusion is a developer of fusion energy technology used to offer environment-friendly and safe energy.
Solving global food and nutrition challenges by unleashing the true potential of microalgae.
Valo Therapeutics is an immunotherapy company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.
VarmX B.V. is manufacturing therapeutic proteins to instantaneously restore blood clotting in bleeding patients.
Wooptix is the first spin-off company. The technology has broad applications, from 3D acquisition using a single camera of a mobile phone
Agurotech offers farm registry, profitability management, irrigation management, pesticide management, and carbon farming solutions.
Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.
EBAMed develops innovative solutions for non-invasive and automated treatment of heart arrhythmias by using ion beams.
Novus Diagnostics are developing a revolutionary sample-to-answer sepsis diagnostic device.
.Lumen is a research startup that uses AI, robotics, and neuroscience to empower the blind.
chipmaker for advanced optical chips
Odd.Bot develops autonomous farming robots that eliminate weeds without chemicals, promoting environmentally friendly agriculture.
Arborea is industrialising photosynthesis to expand the world's food supply
Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).
NeuoKaire develops a personalized medical testing tool to better treat depression.
Embotech is an IT consulting firm that provides autonomous driving solutions for industrial logistics applications.
Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.
Elicit Plant is an agro-biotech company thatfocuses on enhancing the resilience of crops under drought conditions through natural processes.
European Innovation Council has invested in 594 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
European Innovation Council's top investment sectors include Health Care, Biotechnology, Medical, Software, Semiconductor. The firm invests across 46 different industry categories.
Among tracked funding rounds, Marvel Fusion received $53.9M in a Series B round. European Innovation Council's total known invested capital is $4.8B.
European Innovation Council's average investment size is $11.3M across its portfolio of 594 companies.
Recent European Innovation Council portfolio additions include VSORA, DePoly, AMT Medical, Skytree, Sparrow Quantum. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors